Cargando…
The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
Objective: To report a case of a non-arteritic anterior ischemic optic neuropathy (NAAION) in a patient treated with Sumatriptan. Materials and methods: NAAION represents a severe affection that frequently determines irreversible visual acuity damage. The exact cause is yet to be identified, but is...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Romanian Society of Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773116/ https://www.ncbi.nlm.nih.gov/pubmed/36589336 http://dx.doi.org/10.22336/rjo.2022.62 |
_version_ | 1784855128932614144 |
---|---|
author | Dăscălescu, Dana Corbu, Cătălina Șram, Livia Coviltir, Valeria Constantin, Mihaela Burcel, Miruna Marinescu, Maria Comber, Andrei Potop, Vasile |
author_facet | Dăscălescu, Dana Corbu, Cătălina Șram, Livia Coviltir, Valeria Constantin, Mihaela Burcel, Miruna Marinescu, Maria Comber, Andrei Potop, Vasile |
author_sort | Dăscălescu, Dana |
collection | PubMed |
description | Objective: To report a case of a non-arteritic anterior ischemic optic neuropathy (NAAION) in a patient treated with Sumatriptan. Materials and methods: NAAION represents a severe affection that frequently determines irreversible visual acuity damage. The exact cause is yet to be identified, but is usually connected to the systemic status of the patient. We presented the case of a 53-year-old female patient who complained of visual acuity loss in her right eye, associated with inferior visual field (VF) damage. Patient history revealed migraine attacks, raised arterial blood pressure (BP), mitral valve insufficiency and dyslipidemia. Systemic treatment included Sumatriptan for migraine attacks and Bisoprolol for arterial hypertension. Results: A complete ophthalmologic examination was performed, including a visual field examination and optic coherence tomography. Interdisciplinary consults, along with inflammatory biomarkers, brain scan and cardiovascular Doppler echography were used to establish the final diagnosis. Considering the patient’s history, systemic medication, clinical picture, paraclinical findings and interdisciplinary check-ups, NAAION was established as a diagnosis. Discussion: NAAION occurs more frequently after the age of 50 years old and may be associated with systemic factors such as nocturnal hypotension, diabetes, atherosclerosis, sleep apnea. In the present case, the association of medically induced nocturnal hypotension and vasoconstriction led to optic nerve ischemia. Conclusions: In a patient with multiple pathology, we must consider the systemic therapy when performing any clinical examination. Abbreviations: AAION = arteritic anterior ischemic optic neuropathy, AION = anterior ischemic optic neuropathy, BCVA = best corrected visual acuity, BP = blood pressure, CS = corticosteroid, IOP = intraocular pressure, LE = left eye, MRI = magnetic resonance imaging, NAAION = non-arteritic anterior ischemic optic neuropathy, OCT = optical coherence tomography, ON = optic nerve, OU = both eyes, RE = right eye |
format | Online Article Text |
id | pubmed-9773116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Romanian Society of Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-97731162022-12-30 The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy Dăscălescu, Dana Corbu, Cătălina Șram, Livia Coviltir, Valeria Constantin, Mihaela Burcel, Miruna Marinescu, Maria Comber, Andrei Potop, Vasile Rom J Ophthalmol Case Reports Objective: To report a case of a non-arteritic anterior ischemic optic neuropathy (NAAION) in a patient treated with Sumatriptan. Materials and methods: NAAION represents a severe affection that frequently determines irreversible visual acuity damage. The exact cause is yet to be identified, but is usually connected to the systemic status of the patient. We presented the case of a 53-year-old female patient who complained of visual acuity loss in her right eye, associated with inferior visual field (VF) damage. Patient history revealed migraine attacks, raised arterial blood pressure (BP), mitral valve insufficiency and dyslipidemia. Systemic treatment included Sumatriptan for migraine attacks and Bisoprolol for arterial hypertension. Results: A complete ophthalmologic examination was performed, including a visual field examination and optic coherence tomography. Interdisciplinary consults, along with inflammatory biomarkers, brain scan and cardiovascular Doppler echography were used to establish the final diagnosis. Considering the patient’s history, systemic medication, clinical picture, paraclinical findings and interdisciplinary check-ups, NAAION was established as a diagnosis. Discussion: NAAION occurs more frequently after the age of 50 years old and may be associated with systemic factors such as nocturnal hypotension, diabetes, atherosclerosis, sleep apnea. In the present case, the association of medically induced nocturnal hypotension and vasoconstriction led to optic nerve ischemia. Conclusions: In a patient with multiple pathology, we must consider the systemic therapy when performing any clinical examination. Abbreviations: AAION = arteritic anterior ischemic optic neuropathy, AION = anterior ischemic optic neuropathy, BCVA = best corrected visual acuity, BP = blood pressure, CS = corticosteroid, IOP = intraocular pressure, LE = left eye, MRI = magnetic resonance imaging, NAAION = non-arteritic anterior ischemic optic neuropathy, OCT = optical coherence tomography, ON = optic nerve, OU = both eyes, RE = right eye Romanian Society of Ophthalmology 2022 /pmc/articles/PMC9773116/ /pubmed/36589336 http://dx.doi.org/10.22336/rjo.2022.62 Text en #x00A9; The Authors.Romanian Society of Ophthalmology https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Dăscălescu, Dana Corbu, Cătălina Șram, Livia Coviltir, Valeria Constantin, Mihaela Burcel, Miruna Marinescu, Maria Comber, Andrei Potop, Vasile The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy |
title | The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
|
title_full | The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
|
title_fullStr | The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
|
title_full_unstemmed | The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
|
title_short | The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
|
title_sort | pathophysiology of sumatriptan induced non-arteritic anterior ischemic optic neuropathy |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773116/ https://www.ncbi.nlm.nih.gov/pubmed/36589336 http://dx.doi.org/10.22336/rjo.2022.62 |
work_keys_str_mv | AT dascalescudana thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT corbucatalina thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT sramlivia thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT coviltirvaleria thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT constantinmihaela thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT burcelmiruna thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT marinescumaria thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT comberandrei thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT potopvasile thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT dascalescudana pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT corbucatalina pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT sramlivia pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT coviltirvaleria pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT constantinmihaela pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT burcelmiruna pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT marinescumaria pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT comberandrei pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy AT potopvasile pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy |